Ken Anhalt
In addition to MMS, Ken serves on the board of directors of Doppler Veterinary Network. Prior to joining Lindsay Goldberg, Ken worked as an investor at Blackstone in New York and at Bain Capital in Boston.
Ken earned his MBA from Harvard Business School, where he was a George F. Baker Scholar and the recipient of the John L. Loeb finance award, and his A.B. in Economics from Princeton University.
Suggested For You
perspectives
May 6th, 2025
Why Clinical Trial Simulation Is Reshaping Drug Development: A Q&A with Dr. Aiden Flynn
perspectives
April 24th, 2025
How to Derisk Clinical Development with Unified Trial Design and Regulatory Strategy
perspectives
April 8th, 2025
Updated UK Clinical Trial Regulation: The Key Changes and Impact on Development Safety Update Report (DSUR) Requirements
